Michael A. Gallo, Ph.D., D.A.B.T.
Dr. Gallo is a Professor in the UMDNJ-Robert Wood Johnson Medical School Department of Environmental and Occupational Medicine. He is a Diplomate of the American Board of Toxicology, and a Fellow of the Academy of Toxicological Sciences. Dr Gallo is an Adjunct Professor both in the UMDNJ-School of Public Health and in the Department of Pharmacology and Toxicology in the Ernest Mario School of Pharmacy of Rutgers University. He is a founding member of the Environmental and Occupational Health Sciences Institute where he served as Director of Toxicology, and as Director of the NIEHS Center of Excellence. He was the founding Director of the Cancer Institute of New Jersey and Associate Dean for Research. Dr. Gallo is a renowned toxicologist with expertise in the area of dioxins and PCBs, experimental models in pharmacology and toxicology, cytoplasmic and cell surface receptors, hormone biology and mechanisms of hormonal and environmental carcinogenesis. His avocation is History of Toxicology. Dr. Gallo served on several NIH committees including the ALTOX-4 Study Section, Chair of the Board of Scientific Councilors of the National Toxicology Program, and member of the NIEHS Board of Councilors. He also served as Chair of the NCI Centers Review committee, as well as a member of several NAS/NRC Expert committees including Drinking Water and Health; Pesticides in the Diets of Infants and Children; Risk Assessment Methodology; and the National Research Council/Institute of Medicine Roundtable on Environmental Health Sciences, Research and Medicine. He served the US-EPA as a member of the Scientific Advisory Board, and the Dioxin Review Science Advisory Board. Dr. Gallo was Chair of the New Jersey Governor's Pesticide Control Council, and the New Jersey Cancer Risk Commission. Dr. Gallo serves as a consultant to the academic, government and private sectors.
Dioxins; Experimental Models; Pharmacology and Toxicology; Ocular Toxicity; Cytoplasmic Receptors; Hormones; Mechanisms of Carcinogenesis; Cell Surface Receptors; and Chemical Carcinogenesis
2011 Society of Toxicology Education Award
2001 Chair, Hormonal Carcinogenesis Gordon Research Conference
2000 Ambassador of Toxicology, Mid-Atlantic Society of Toxicology
1985 Chair, Mechanisms of Toxicity Gordon Research Conference
1985 UMDNJ Exceptional Merit Award
1979 Russell Sage College Outstanding Alumni
1971-1972 NIH Post Doctoral Fellow
1968-1971 NIH Pre-Doctoral Fellow
Tian, Y., Ke, S., Denison, M.S., Rabson, A.B., and Gallo, M.A. (1999). Interaction between the Ah receptor and NF-kB Signal Transduction Pathway: Potential Mechanism for Dioxin Toxicity and Alteration of Gene Expression of Xenobiotics. J. Biol. Chem. 274:510-515.
Turan, V.K., Sanchez, R.I., Li, J.J., Li, S.A., Reuhl, K.R., Thomas, P.E., Conney, A.H., Gallo, M.A., Kauffman, F.C., and Mesia-Vela, S. (2004). The Effects of Steroidal Estrogens in ACI Rat Mammary Carcinogenesis: 17-beta estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16-alpha hydroxyestradiol, and 4-hydroxyestrone. Journ. Of Endocrin., 183:91-99.
Thomas, T., Gallo, M.A., and Thomas, T.J. (2004). Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases. Current Canc. Drug Targets, 4:483-499.
Gu, X., Ke, S., Liu, D., Sheng, T., Thomas, P.E., Rabson, A.B., Gallo, M.A., Xie, W., and Tian, Y. (2006) Role of NF-kB in Regulation of PXR-mediated Gene Expression: A Mechanism for the Suppression of Cytochrome P450 3A4 by Pro-inflammatory Agents. J. Bio Chem.
Vijayanathan, V., Greenfield, N.J., Thomas, T.J., Ivanova, M.M., Tyulmenkov, V.V., Klinge, C.M., Gallo, M.A., and Thomas T. (2007). Effects of Estradiol and 4-hydroxytamoxifen on the Conformation, Thermal Stability, and DNA Recognition of Estrogen Receptor-beta. Biochem. Cell Biol. 85:1-10.
Nair,S.K., Verma,A., Thomas, T.J., Gallo, M.A., Shirahata, A., and Thomas, T. (2007). Synergistic apoptosis of MCF-7 Breast Cancer Cells by 2-Methoxyestradiol and bis(ethyl)norspermine. Cancer Letters.250(2): 311-322.
Goodin,S., Shen,F., Shih, W. J., Dave, N., Kane, M. P., Medina, P., Lambert, G.H., Aisner, J., Gallo, M.A., and DiPaola, R.S. (2007). Clinical and Biological Activity of Soy protein powder Supplementation in Healthy male Volunteers. Cancer Epidemiol. Biomarkers Prev. 16(4): 829-833.
DiPaola, R.S. and Gallo, M.A. (2008). Hearsay Medicine is not Evidence-Based Medicine (editorial). Clin cancer Res (14(2). 337-338.
Zhu, B.T., Gallo, M.A., Burger, C.W., Meeker, R.J., May, X. C., Xu, S., and Conney, A.H. (2008). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin administration and high fat diet on the body weight and hepatic estrogen metabolism in female C3H/HeN mice. Toxicol Appl Pharmacol 226: 107-118.
Gordon,M.K., Desantis, A., Deshmukh, M., Jacey, C.J., Hahn, R.A., Belomi, J., Anumolu, S.S., Schlager, J.J., Gallo, M.A., Gerecke, D.R., Heindel, N.D., Svoboda, K.K., Babin, M.C., and Sinko, P.J. (2010).Doxycycline hydrogels as a potential therapy for ocular vesicant injury. J Ocul Pharmacol Ther. 26(5):407-419.
Zarbl, H., Gallo, M.A., Glick, J., Yeung, K.Y., and Vouros, P. (2010). The vanishing zero: Thresholds in the age of genomics. Chemico-Biological Interactions (184): 273-278.